Member Info for Laura2022

Morning Roly,this may answer your thoughts. From the June update

as significantly lowered its operating cost base recently and expects to improve its financial performance in the next few months against a backdrop of further sales order growth so far in the first quarter of this financial year.

Morning both

So does he currently work for PYC ? And what might be the significance?

I have posted some recent summary points over the last few weeks so will try to re post them

Hello Oman

They are due in Sept for the year ended June , a pre close update was given in May if that helps , the year July 2023 onwards appears to have started very well as per the various RNSs July July to Sept 2023

Ab201

I can see from my green filter lists that you're wasting your time talking to known trolls.just ignore

L

The last time those blue bars changed shape/direction the price went 1p to 3.2p

Cam the same happen here again?.

2.3p to ????? Maybe 5p +

Is that how these charts work ?

Thanks both

Thought it was just HL again

I now cannot buy anything...is that right?

At 2.2p there seems to only be £1500-2000 available

Cannot get a quote at 2p to buy

Thankyou for this msuk

I have been purchasing more today and yesterday

The dementia test could be life changing

Physiomics (AIM:PYC) is a computational systems biology services company applying simulations of cell behaviour to drug development to reduce the high attrition rates of clinical trials. As 80-90 per cent of all clinical drug candidates fail to reach the market, estimates1 show that an overall ten per cent improvement in success rates could reduce the cost of one drug’s development by as much as $242 million, from the current estimate of around $800 million. Physiomics develops computational systems biology models to predict and understand cancer drug

Well said Acker

Quite why people spend 2 yrs on here and VAL spreading lies and mistaken opinions is beyond me

Please find something else to do with your time Porky

Why DID you end up not doing due diligence on DDDD and losing everything ?

Thanks for the update on Cellcentric

Are they UK or USA please ?

Trying to work out if Noel is more popular here or on DELT

Ackers

Good morning Ackers

Sorry for later reply

Excellent summary of the potential spending that cone to PYC from long established clients, for confidentiality PYC often aren't allowed to day much but the recent contract used the word "SUBSTANTIAL: which clearly shows q step change from usual .

PYC have recently had new collabs from Bicycle, who raised appox $240m.

They helped with Cellcentric with CCS1477 ( now inobrodib )and they have just raised approx $20m and had fast track orphan status from FDA.

Numab secured $110m funding in 2021.

You could hope that a fraction of those $ or £ raised ( at least ) could come PYC's way to help with projects either already started or in the future from these companies?

Then there is the £6m from VAL for (201) as shown in Feb 2021 RNS ( still not a certainly of course but VAL CEO says still by end of 2023 for deal)

Yes Jimmy

And these areas have $$blns of funding and PYC is one of the few UK liste detocks involved in A.I /oncology that can meet the newly flourishing sectors of A.I in drug development and also Personalised medicine

Looks like more volume amd more interest with multiple news items due and more of the new opportunities plus the £1.5mln pipeline of confirmed deals for 2023/24